§ EQUITY
USD

EIKN

EIKON THERAPEUTICS INC
USD
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
Fidelity Management2.7M0.0%n/a
Foresite Capital Management IV, LLC1.9M8.7%n/a
Merck & Co., Inc.1.7M5.0%n/a
BlackRock, Inc.1.6M0.0%n/a
Foresite Capital Management V, LLC1.3M5.1%n/a
Capital World Investors1.1M0.0%n/a
AC INTELLIGENCE

Top institutional owners for EIKN as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER52.9% · 28 holders
QUALITY / COMPOUNDER27.2% · 5 holders
PASSIVE / INDEX15.1% · 3 holders
TACTICAL / MACRO2.1% · 4 holders
DEALER / BANK1.7% · 8 holders
INCOME / DEFENSIVE0.9% · 2 holders
SYSTEMATIC / QUANT0.1% · 2 holders
AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
AC INTELLIGENCE

No Form 4 filings on record for EIKN in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention EIKN yet.